PARP14 is an interferon-induced host factor that promotes IFN production and affects the replication of multiple viruses.
Saved in:
| Title: | PARP14 is an interferon-induced host factor that promotes IFN production and affects the replication of multiple viruses. |
|---|---|
| Authors: | Parthasarathy S; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA., Saenjamsai P; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA., Hao H; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA., Ferkul A; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA., Pfannenstiel JJ; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA., Bejan DS; Department of Chemical Physiology and Biochemistry, Oregon Health Sciences University, Portland, Oregon, USA., Chen Y; Department of Molecular Biosciences, University of Texas, Austin, Texas, USA., Suder EL; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA.; Center for Emerging Infectious Diseases Policy & Research, Boston University, Boston, Massachusetts, USA., Schwarting N; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA., Aikawa M; Center for Excellence in Vascular Biology (P.K.J.E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Center for Interdisciplinary Cardiovascular Sciences (M.A.E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Channing Division of Network Medicine (M.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Muhlberger E; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA.; Center for Emerging Infectious Diseases Policy & Research, Boston University, Boston, Massachusetts, USA., Hume AJ; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA.; Center for Emerging Infectious Diseases Policy & Research, Boston University, Boston, Massachusetts, USA., Orozco RC; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA., Sullivan CS; Department of Molecular Biosciences, University of Texas, Austin, Texas, USA., Cohen MS; Department of Chemical Physiology and Biochemistry, Oregon Health Sciences University, Portland, Oregon, USA., Davido DJ; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA., Fehr AR; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas, USA. |
| Source: | MBio [mBio] 2025 Oct 08; Vol. 16 (10), pp. e0229925. Date of Electronic Publication: 2025 Sep 12. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2150-7511 (Electronic) NLM ISO Abbreviation: mBio Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
